Venous Leg Ulcer clinical trials at UC Health
3 in progress, 1 open to eligible people
Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01)
open to eligible people ages 18 years and up
It is hypothesized that application at 4-week intervals of the human umbilical cord tissue TTAX01 to the surface of a well debrided, nonhealing venous leg ulcer (VLU) will result in a high proportion of wounds showing complete healing within 12 weeks of initiating therapy. This open label pilot study provides a framework for a larger, controlled study. The purposes for conducting this study are to evaluate the functionality of the protocol and to obtain an estimate of product safety and efficacy when applied according to the protocol instructions, and measured according to the stated endpoints.
Sorry, not yet accepting patients
This study in venous leg ulcer (VLU) patients will evaluate the use of Cirvo™ therapy for the treatment of VLU when applied for a minimum of two hours daily for up to 12 weeks.
VLU Non-inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-layer Bandaging
Sorry, in progress, not accepting new patients
The purpose of the study is to test non-inferiority of chronic Venous Leg Ulcer (VLU) area closure at 16 weeks with a dual action pneumatic compression device compared to multi-layer bandaging.
at UCLA UCSD